시장보고서

상품코드

1575021

POC 감염증 검사 시장 : 질병 유형별, 기술별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

PoC Infectious Disease Testing Market, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 10월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 322 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

2023년 POC 감염증 검사 시장 규모는 2023년 114억 9,832만 달러로 2024년부터 2032년까지 CAGR 4.40%로 확대될 것으로 예상됩니다.

POC 감염증 검사 시장 - 시장 역학

감염병 확산과 신속한 진단의 필요성 증가, 디지털화가 시장 수요를 촉진할 것으로 예상

COVID-19, 독감, HIV, 결핵, 성병 등 감염성 질환의 증가로 인해 신속하고 신뢰할 수 있는 진단에 대한 수요가 증가하고 있으며, PCR과 같은 분자진단, 면역분석, 미세 유체 등 검사 기술의 혁신으로 POCT 장비의 민감도, 특이성, 사용 편의성이 향상되어 POCT 장비에 대한 수요가 증가하고 있습니다. POCT 장비의 민감도, 특이성, 사용 편의성이 향상되어 POC 검사에 대한 수요가 증가하고 있습니다. 또한 조기 진단과 정기적인 검진의 이점에 대한 대중의 인식이 높아지면서 시장 성장에 기여하고 있습니다.

또한, POCT는 전문 검사 시설과 인력이 필요하지 않기 때문에 전체 검사 비용을 절감할 수 있으며, POCT 기기를 디지털 건강 플랫폼 및 전자 의료 기록(EMR)과 통합하여 원활한 데이터 공유, 원격 모니터링 및 질병 관리를 개선할 수 있습니다. 신흥국은 의료 인프라와 숙련된 인력 부족을 해결하기 위해 POCT 솔루션을 채택하고 있습니다. 커넥티비티 기능을 통해 질병 발생을 추적하고 역학 감시를 개선할 수 있습니다. 이러한 장점은 시장 성장을 촉진할 것으로 예상됩니다.

POC 감염증 검사 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032) 동안 연평균 약 4.40%의 CAGR로 매년 성장할 것으로 예상됩니다.

질병 유형별로 보면 2023년에는 신속한 진단에 대한 높은 수요로 인해 COVID-19 질환이 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

기술별로는 분자 검사의 발전으로 2023년 분자진단약 부문이 주요 기술 부문으로 부상했습니다.

최종사용자별로는 POC 진단 연구소 및 센터 등의 증가로 인해 2023년 최종사용자 중 진료소가 가장 많은 비중을 차지했습니다.

지역별로 보면 북미는 첨단 헬스케어 기술과 인프라가 존재하기 때문에 2023년 주요 수익원이었습니다.

POC 감염증 검사 시장 - 세분화 분석:

세계 POC 감염증 검사 시장은 질병 유형, 기술, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 질병 유형에 따라 HIV, 독감, 결핵 및 약물 내성 POC, HBV POC, HPV POC, COVID-19 질병, 기타 등 7가지 범주로 나뉘며, COVID-19 질병 부문이 시장을 주도하고 있습니다. 수요 증가가 이 부문의 성장을 견인하고 있습니다.

시장은 기술에 따라 측면 흐름 면역측정법, 응집 검사, 분자진단법, 기타 등 4가지로 분류됩니다. 시장을 독점하고 있는 것은 분자진단 분야입니다. 분자 검사는 정확도가 높고 유전자 재료 처리에 적합하기 때문에 이 분야의 수요가 가속화되고 있습니다.

시장은 최종사용자에 따라 병원, 클리닉, 재택의료, 기타 등 4가지로 분류됩니다. 클리닉 시장이 시장을 지배하고 있으며, 예측 기간 동안 높은 우위를 유지할 것으로 예상되며, POC 감염에 대한 신속한 치료를 제공하는 임상 센터의 증가가 시장 성장을 촉진하고 있습니다.

POC 감염증 검사 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 분포되어 있습니다. 북미, 특히 미국은 선진화된 의료 인프라, 높은 질병 부담, 신속한 진단에 대한 높은 관심으로 인해 전 세계 POCT 시장에서 가장 큰 점유율을 차지하고 있습니다. 아시아태평양은 인구가 많고, 전염병 유행이 증가하고, 조기 진단에 대한 인식이 높아짐에 따라 가장 높은 성장률을 보일 것으로 예상되며, 특히 농촌 및 외딴 지역에서 집중적인 검사 시설에 대한 접근성 부족을 해결하기 위해 POCT의 도입이 진행되고 있습니다.

POC 감염증 검사 시장 - 경쟁 상황:

POC 감염증 검사 시장은 경쟁이 치열하고 수많은 세계 및 지역 기업이 존재하는 것이 특징입니다. 각 기업들은 클라우드 기반 데이터 관리 및 원격 모니터링과 같은 디지털 헬스 솔루션을 POCT 제품에 통합하기 위해 투자를 늘리고 있습니다. 또한, 업체들은 CRISPR 기반 진단약과 자동 디지털 판독기 등 차세대 기술을 통해 POCT 기기의 민감도와 특이도를 향상시키는 데 주력하고 있습니다.

2024년 1월, 로슈는 루미라덱스의 POCT 기술 인수를 완료했습니다. 루미라덱스의 플랫폼에는 일련의 면역측정 및 임상 화학 검사가 포함되어 있습니다.

2023년 2월, 써모피셔 사이언티픽은 마이랩과 제휴하여 인도에서 감염성 질환용 RTPCR 키트를 출시했습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - POC 감염증 검사 업계

경쟁 대시보드
기업 개요
- Abbott Laboratories
- Roche Diagnostics
- QuidelOrtho Corporation
- Siemens Healthineers
- Becton, Dickinson and Company
- Cepheid
- bioMerieux
- Thermo Fisher Scientific
- Hologic, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific
- Chembio Diagnostics, Inc.
- PerkinElmer, Inc.
- Sekisui Diagnostics
- Trinity Biotech plc
- Others

제12장 애널리스트의 전방위 전망

ksm 24.11.06

REPORT HIGHLIGHT

PoC Infectious Disease Testing Market size was valued at USD 11,498.32 Million in 2023, expanding at a CAGR of 4.40% from 2024 to 2032.

Point of Care Infectious Disease Testing (POCT) refers to diagnostic tests conducted at or near the site of patient care, such as in a clinic, doctor's office, or at home. These tests are designed to detect infectious diseases quickly, providing results within minutes to a few hours. This enables healthcare providers to make immediate decisions about treatment and management, reducing the need for additional lab testing and follow-up visits.

PoC Infectious Disease Testing Market- Market Dynamics

Increasing prevalence of infectious diseases and need for rapid diagnostics along with digitization is expected to propel market demand

The increasing incidence of infectious diseases like COVID-19, influenza, HIV, tuberculosis, and sexually transmitted infections has heightened the demand for rapid and reliable diagnostics. Innovations in testing technologies, including molecular diagnostics like PCR, immunoassays, and microfluidics, have improved the sensitivity, specificity, and ease of use of POCT devices, boosting demand for POC testing. Public awareness regarding the benefits of early diagnosis and regular screening is also rising, contributing to market growth.

Further, POCT reduces the overall cost of testing by eliminating the need for specialized lab facilities and personnel. Integration of POCT devices with digital health platforms and electronic medical records (EMRs) allows for seamless data sharing, remote monitoring, and improved disease management. Emerging economies are adopting POCT solutions to address the shortage of healthcare infrastructure and skilled personnel. Connectivity features enable better tracking of disease outbreaks and epidemiological surveillance. These benefits are expected to bolster market growth.

PoC Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.40% over the forecast period (2024-2032)

Based on Disease Type segmentation, the COVID-19 disease segment was predicted to show maximum market share in the year 2023, owing to high need for fast diagnostics.

Based on Technology segmentation, molecular diagnostics segment was the leading Technology segment in 2023, due to the developments in molecular testing.

Based on End User segmentation, clinics segment was the leading End User segment in 2023, due to increasing number of POC diagnostics labs, centers, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of advanced healthcare technology and infrastructure.

PoC Infectious Disease Testing Market- Segmentation Analysis:

Global PoC Infectious Disease Testing Market is segmented on the basis of Disease Type, Technology, End User, and Region.

The market is divided into seven categories based on Disease Type: HIV, influenza, TB & drug resistant POC, HBV POC, HPV POC, COVID-19 disease, and others. The COVID-19 disease segment dominates the market. The increasing demand from PCR testing for COVID-19 has boosted segment growth.

The market is divided into four categories based on Technology: lateral flow immunoassay, agglutination test, molecular diagnostics, and others. The molecular diagnostics segment dominates the market. The molecular tests are accurate and preferred in genetic material processing which is accelerating segment demand.

The market is divided into four categories based on End User: hospitals, clinics, homecare, and others. The clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising number of clinical centers providing rapid treatment in POC infectious diseases is boosting market growth.

PoC Infectious Disease Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, particularly the United States, holds the largest share of the global POCT market due to its advanced healthcare infrastructure, high disease burden, and strong emphasis on rapid diagnostics. The Asia-Pacific region is expected to witness the highest growth rate due to the large population base, rising prevalence of infectious diseases, and growing awareness about early diagnosis. The adoption of POCT is particularly high in rural and remote areas to address the lack of access to centralized laboratory facilities.

PoC Infectious Disease Testing Market- Competitive Landscape:

The PoC Infectious Disease Testing market is highly competitive and characterized by the presence of numerous global and regional players. Companies are increasingly investing in integrating digital health solutions, such as cloud-based data management and remote monitoring, into their POCT products. In addition, companies are focusing on enhancing the sensitivity and specificity of their POCT devices through next-generation technologies, such as CRISPR-based diagnostics, and automated digital readers.

In January 2024, Roche completed acquisition of LumiraDx's point of care technology. The LumiraDx's platform includes a series of immunoassay and clinical chemical tests.

In February 2023, Thermo Fisher Scientific partnered with Mylab to introduce RTPCR kits for infectious disease in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS

Abbott Laboratories
Roche Diagnostics
QuidelOrtho Corporation
Siemens Healthineers
Becton, Dickinson and Company
Cepheid
bioMerieux
Thermo Fisher Scientific
Hologic, Inc.
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific
Chembio Diagnostics, Inc.
PerkinElmer, Inc.
Sekisui Diagnostics
Trinity Biotech plc
Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

HIV
Influenza
TB & drug resistant POC
HBV POC
HPV POC
COVID-19 disease
Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

Lateral flow immunoassay
Agglutination test
Molecular diagnostics
Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospital
Clinics
Homecare
Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. PoC Infectious Disease Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. PoC Infectious Disease Testing Market Snippet by Disease Type
- 2.1.2. PoC Infectious Disease Testing Market Snippet by Technology
- 2.1.3. PoC Infectious Disease Testing Market Snippet by End User
- 2.1.4. PoC Infectious Disease Testing Market Snippet by Country
- 2.1.5. PoC Infectious Disease Testing Market Snippet by Region
2.2. Competitive Insights

3. PoC Infectious Disease Testing Key Market Trends

3.1. PoC Infectious Disease Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. PoC Infectious Disease Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. PoC Infectious Disease Testing Market Opportunities
3.4. PoC Infectious Disease Testing Market Future Trends

4. PoC Infectious Disease Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. PoC Infectious Disease Testing Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. PoC Infectious Disease Testing Market Landscape

6.1. PoC Infectious Disease Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. PoC Infectious Disease Testing Market - By Disease Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
- 7.1.2. HIV
- 7.1.3. Influenza
- 7.1.4. TB & drug resistant POC
- 7.1.5. HBV POC
- 7.1.6. HPV POC
- 7.1.7. COVID-19 disease
- 7.1.8. Others

8. PoC Infectious Disease Testing Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 8.1.2. Lateral flow immunoassay
- 8.1.3. Agglutination test
- 8.1.4. Molecular diagnostics
- 8.1.5. Others

9. PoC Infectious Disease Testing Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospital
- 9.1.3. Clinics
- 9.1.4. Homecare
- 9.1.5. Others

10. PoC Infectious Disease Testing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. PoC Infectious Disease Testing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. PoC Infectious Disease Testing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. PoC Infectious Disease Testing Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. PoC Infectious Disease Testing Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. PoC Infectious Disease Testing Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PoC Infectious Disease Testing Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Roche Diagnostics
- 11.2.3. QuidelOrtho Corporation
- 11.2.4. Siemens Healthineers
- 11.2.5. Becton, Dickinson and Company
- 11.2.6. Cepheid
- 11.2.7. bioMerieux
- 11.2.8. Thermo Fisher Scientific
- 11.2.9. Hologic, Inc.
- 11.2.10. Bio-Rad Laboratories, Inc.
- 11.2.11. Thermo Fisher Scientific
- 11.2.12. Chembio Diagnostics, Inc.
- 11.2.13. PerkinElmer, Inc.
- 11.2.14. Sekisui Diagnostics
- 11.2.15. Trinity Biotech plc
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us